1 week ago
33
A new oral approach to GLP-1 treatment helped adults with obesity or overweight lose as much as 12 percent of their body weight over 36 weeks, according to a randomized phase II clinical trial published in Nature Medicine.
Robert Kushner, MD, '82 GME, professor emeritus of Medicine in the Division of Endocrinology, Metabolism and Molecular Medicine, was a co-author of the study.
A GLP-1 Drug That Comes as a Pill
Alenigli...
English (US) ·